tiprankstipranks
Universe Pharmaceuticals Incorporation (UPC)
:UPC
US Market

Universe Pharmaceuticals (UPC) Income Statement

Compare
187 Followers

Universe Pharmaceuticals Income Statement

Last quarter (Q2 2024), Universe Pharmaceuticals's total revenue was $12.88M, a decrease of -46.76% from the same quarter last year. In Q2, Universe Pharmaceuticals's net income was $-13.10M. See Universe Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
$ 32.31M$ 40.14M$ 47.98M$ 30.70M$ 33.23M
Gross Profit
$ 10.32M$ 21.89M$ 25.33M$ 14.09M$ 13.41M
Operating Expenses
$ 13.84M$ 28.91M$ 11.74M$ 3.74M$ 3.36M
Depreciation and Amortization
$ 508.79K$ 533.95K$ 446.88K$ 410.08K$ 418.43K
EBITDA
$ -3.22M$ -7.33M$ 14.20M$ 10.61M$ 10.17M
Operating Income
$ -3.53M$ -7.02M$ 13.59M$ 10.25M$ 9.75M
Other Income/Expenses
$ -322.80K$ -545.35K$ 88.34K$ -151.29K$ -99.77K
Pretax Income
$ -3.85M$ -7.98M$ 13.68M$ 10.10M$ 9.65M
Net Income
$ -6.16M$ -8.74M$ 11.32M$ 7.56M$ 7.55M
Per Share Metrics
Basic EPS
$ -1.70$ -2.41$ 3.12$ 2.06$ 2.05
Diluted EPS
$ -1.70$ -2.41$ 3.12$ 2.06$ 2.05
Weighted Average Shares Outstanding
3.63M 3.63M 3.63M 3.67M 3.67M
Weighted Average Shares Outstanding (Diluted)
3.63M 3.63M 3.63M 3.67M 3.67M
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis